Drug intelligence / Profile preview

LKB1 siRNA

Development stage
Unknown
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral, Intravenous, Intraperitoneal
01

Overview

LKB1 siRNA is a small interfering RNA (siRNA) designed to silence the expression of the Liver Kinase B1 (LKB1) gene, also known as STK11 (Serine/Threonine Kinase 11). LKB1 is a master upstream kinase that phosphorylates and activates AMP-activated protein kinase (AMPK), a central regulator of cellular energy metabolism, growth, and polarity. By reducing LKB1 protein levels, LKB1 siRNA inhibits the LKB1/AMPK signaling axis, which is often investigated in the context of cancer cell survival, apoptosis, and autophagy. In research settings, such as studies on head and neck cancer, LKB1 siRNA has been used to demonstrate that LKB1 is required for certain types of cell death induced by the silencing of other proteins like β-catenin. While primarily used as a research tool to study tumor suppressor functions and metabolic stress responses, the targeting of LKB1 via RNA interference represents a strategy for modulating pathways involved in tumorigenesis and therapy resistance.

Other names
STK11 siRNASTK-11 siRNASTK 11 siRNAliver kinase B1 siRNAserine/threonine kinase 11 siRNA
02

Targets

STK11 (Serine/threonine kinase 11)

Beyond the preview

Go deeper on LKB1 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LKB1 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call